QA: Sybleu Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818674_2022_Sybleu_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001818674, Sybleu Inc

  xvar xval
0 AssetsCurrent 14,297
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 185,250
4 LiabilitiesCurrent 30,763
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 173,398
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,013
9 ResearchAndDevelopmentExpense 29,411
10 remainder_Expenses 76,274
11 remainder_Revenues 4,052
12 remainder_NetIncome 7,800
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 199,547
1 Liabilities 204,161
2 Expenses 113,698
3 Revenues 4,052
4 StockholdersEquity -4,614
5 NetIncome -101,846
6 ComprehensiveNetIncome -101,846
7 BaseVar 264,629
8 EconomicCapitalRatiobeforeLimitedLiability -0.554
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution